You may also like
Vasopressor Therapy in Cardiac Surgery—An Experts’ Consensus Statement
The authors unanimously and weakly recommend that clinicians consider early addition of a second vasopressor (norepinephrine or vasopressin) if adequate vascular tone cannot be restored by a monotherapy with either norepinephrine or vasopressin and to consider using vasopressin as a first-line vasopressor or to add vasopressin to norepinephrine in cardiac surgical patients with pulmonary hypertension or right-sided heart dysfunction.
Cytokine Adsorption in Patients with Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation
With this study, we expect to clarify whether cytokine adsorption is beneficial in severely affected COVID-19 patients requiring vv-ECMO support.
The Pulse on Perfusion: Organ Donation and the Future of Transplant Innovation
Every month, The Pulse on Perfusion gives us a snapshot of what perfusionists are thinking, questioning, and debating, and this latest poll is no exception. From the emotional core of organ donation to the fast-moving world of transplant innovation, respondents offered thoughtful, experience-driven perspectives that reflect both the realities of the OR and the future they hope to see. These insights tell a powerful story: organ transplantation is evolving quickly, but its success still hinges on people, compassion, and practical advancements that make more life-saving procedures possible. Let’s take a closer look at what the community had to say.
